Your browser is no longer supported. Please, upgrade your browser.
Settings
IMRN [NASD]
Immuron Limited
Index- P/E- EPS (ttm)-1.12 Insider Own- Shs Outstand5.60M Perf Week-8.83%
Market Cap30.09M Forward P/E- EPS next Y- Insider Trans- Shs Float5.24M Perf Month-17.89%
Income- PEG- EPS next Q- Inst Own3.59% Short Float0.00% Perf Quarter-22.29%
Sales0.98M P/S30.63 EPS this Y- Inst Trans- Short Ratio0.00 Perf Half Y-34.11%
Book/sh5.04 P/B1.07 EPS next Y- ROA- Target Price6.41 Perf Year168.50%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range1.81 - 28.99 Perf YTD-15.70%
Dividend- P/FCF- EPS past 5Y- ROI- 52W High-81.48% Beta-
Dividend %- Quick Ratio- Sales past 5Y- Gross Margin- 52W Low196.69% ATR0.35
Employees- Current Ratio- Sales Q/Q-98.70% Oper. Margin- RSI (14)34.02 Volatility5.61% 5.48%
OptionableNo Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.64 Prev Close5.59
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume78.35K Price5.37
Recom2.00 SMA20-10.37% SMA50-18.88% SMA200-29.40% Volume49,951 Change-3.94%
Mar-02-21 11:40AM  
Jan-11-21 06:00AM  
Dec-15-20 06:00AM  
Nov-24-20 06:00AM  
Nov-11-20 06:00AM  
Oct-12-20 06:00AM  
Jul-23-20 12:45PM  
Jul-22-20 06:00PM  
Jul-21-20 09:00AM  
08:45AM  
07:00AM  
Jul-20-20 06:00AM  
Jun-19-20 06:00AM  
Jun-15-20 10:29AM  
Jun-10-20 07:30AM  
Jun-09-20 04:10PM  
03:02PM  
06:00AM  
Apr-28-20 06:00AM  
Apr-20-20 06:00AM  
Mar-25-20 07:29AM  
06:00AM  
Mar-18-20 08:17PM  
Mar-03-20 07:00AM  
Feb-03-20 07:30AM  
Jan-28-20 08:30AM  
Jan-08-20 08:00AM  
Nov-21-19 07:00AM  
Nov-13-19 05:28PM  
Nov-04-19 11:30AM  
Oct-14-19 12:46PM  
07:30AM  
Oct-03-19 12:29PM  
Oct-02-19 12:44PM  
09:57AM  
09:00AM  
Sep-24-19 08:22PM  
Sep-04-19 06:00AM  
Aug-16-19 06:00AM  
Aug-12-19 06:30AM  
Aug-08-19 11:04PM  
12:00PM  
Jul-17-19 11:39AM  
06:00AM  
06:00AM  
Jul-16-19 04:31PM  
12:44PM  
06:00AM  
Jun-25-19 06:00AM  
Jun-19-19 08:00AM  
Jun-12-19 02:30PM  
07:00AM  
Jun-07-19 12:48AM  
May-30-19 08:00AM  
May-23-19 09:10PM  
04:45PM  
Apr-30-19 02:36PM  
Apr-17-19 09:00AM  
Apr-15-19 07:00PM  
09:00AM  
Apr-11-19 10:00AM  
09:00AM  
Feb-11-19 07:14PM  
Jan-29-19 09:30AM  
Jan-08-19 02:32AM  
Nov-26-18 07:09PM  
Nov-19-18 09:00AM  
Nov-09-18 06:00AM  
Sep-24-18 10:12PM  
Sep-05-18 10:00AM  
Jul-25-18 10:00AM  
Jul-24-18 06:30AM  
06:28AM  
Jun-25-18 08:36PM  
May-07-18 09:43PM  
Apr-23-18 06:57PM  
09:30AM  
Mar-13-18 06:20PM  
09:30AM  
02:15AM  
Mar-12-18 08:17AM  
Mar-07-18 06:30PM  
05:06PM  
Feb-16-18 09:30AM  
Jan-31-18 09:30AM  
Jan-29-18 09:20AM  
Jan-24-18 09:30AM  
Immuron Limited, a biopharmaceutical company, researches and develops oral immunotherapy polyclonal antibodies for the treatment and prevention of infectious and immune modulated diseases in Australia, the United States, and internationally. The company operates through two segments, Research and Development, and Hyperimmune Products. The company markets Travelan and Protectyn for the prevention of travellers' diarrhea. Its lead product candidates include IMM-124E that is in Phase II clinical trials for non-alcoholic steatohepatitis, severe alcoholic hepatitis, and non-alcoholic fatty liver disease, as well as used in antiviral activity against the COVID-19 virus in laboratory studies; and IMM-529, a clinical stage product for clostridium difficile infections. Immuron Limited was founded in 1994 and is based in Carlton, Australia.